February 22, 2026
Headlines

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

Sumain Faisal01 mins

AstraZeneca’s gefurulimab showed clinical benefits and favorable safety in Phase 3 trial for adults with anti-AChR antibody-positive gMG.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News